GTBP
GT BiopharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GTBP Profile
Gt Biopharma, Inc.
A clinical stage biopharmaceutical company that develops immuno-therapeutic products
--
--
GT Biopharma, Inc., was incorporated in California in 1965. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products with a proprietary tri-specific killer adapter fusion protein immune cell adapter technology platform. TriKE can be designed to target any number of tumor antigens in hematological malignancies or solid tumors and does not require patient-specific customization.
